KINGMAN – Kingman Regional Medical Center (KRMC) has begun using monoclonal antibodies to treat high-risk COVID-19 patients. Monoclonal antibodies are proteins made in a laboratory to mimic the body’s natural immune response. With this treatment, a patient receives an intravenous (IV) infusion of the antibodies. This can enhance the patient’s ability to fight the virus that causes COVID-19. In November, The US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for certain monoclonal antibody therapies. This authorization allows the therapy for COVID-positive patients with high risk for disease progression or hospitalization. Clinical trials suggest that the therapy…

KINGMAN – As COVID-19 cases continue to soar in our community, Kingman Regional Medical Center (KRMC) is asking for the public’s help. Since October, COVID hospitalizations at KRMC have risen by record numbers. The hospital has activated surge plans to accommodate patients who require hospitalization. However, hospital staff are strained. According to Jim Wells, KRMC Chief Nursing Officer, “Our doctors and nurses are exhausted after many months of dealing with COVID. Some are getting sick themselves.” The hospital has been using some travel labor to help care for patients. But, those resources are becoming more limited as hospitals nationwide are…